After securing €46M, LemFi acquires UK fintech Pillar to expand credit access for immigrants globally
Oakland, California-based LemFi, an immigrant financial services platform, announced that it has acquired UK credit fintech firm Pillar.
Popular topics
The economy of building technology — markets, startups, capital flows, and the operating decisions behind ambitious companies.
8,462 articles · Business
Oakland, California-based LemFi, an immigrant financial services platform, announced that it has acquired UK credit fintech firm Pillar.
Scope Biosciences, a deep tech spin-off from Wageningen University & Research, has secured a follow-on investment from SHIFT Invest and Oost NL to advance its CRISPR-based molecular diagnostics platform.
Berlin-based learning platform Knowunity has secured €27M in Series B funding led by XAnge to expand its AI-powered study companion globally.
In a world where managing user access, subscriptions, and sensitive data often involves juggling multiple tools, Veriam steps in as a breath of fresh air.
Startup Genome, in collaboration with the Global Entrepreneurship Network, unveiled its 2025 Global Startup Ecosystem Report (GSER) today at VivaTech in Paris.
London-based Perci Health, a virtual cancer care clinic, announced that it has secured £3M (approximately €3.5M) in fresh funding, bringing its total raised to £7.7M (approximately €9M).
French startup Kolet has secured $10M (approximately €9M) in Series A funding led by Daphni to advance its digital eSIM connectivity platform for travellers.
Maze, an AI-native cloud security platform, has secured $25M (approximately €22.5M) in Series A funding led by Theory Ventures to advance autonomous vulnerability investigation and resolution.
As professionals, we all embrace LinkedIn, right?
Thibault Constant, a lifelong night train traveller and creator of the popular YouTube channel Simply Railway, has announced the launch of his own night train company, Nox Mobility.
Munich-based Co-Power, a company building decentralised energy infrastructure, raised €6.4M led by Cherry Ventures.
Mosanna Therapeutics, a biotech company specialised in the treatment of obstructive sleep apnea (OSA), has secured $80M (approximately €70.1M) in Series A funding.